top of page

News

MedFair2024

Participate in the 15th Hong Kong International Medical and Healthcare Exhibition

Participate in the 15th Hong Kong International Medical and Healthcare Exhibition

news_AKEEGA_FDA

AKEEGA™ receives U.S. FDA Approval for BRCA-Induced Metastatic Castration-Resistant Prostate Cancer (mCRPA)

The approval of AKEEGA™ underscores the critical importance of genetic testing in managing prostate cancer. BRCA gene mutations are linked to more aggressive forms of cancer and can significantly affect treatment decisions and outcomes.

news_Cancer2024

Codex participated in the Cancer 2024 Cancer Immunology Conference

Codex participated in the Cancer 2024 Cancer Immunology Conference, which was held on Saturday, the 13th of this month. The conference was jointly organized by the Organisation for Oncology and Translational Research (OOTR) and the Department of Anatomical and Cellular Pathology at The Chinese University of Hong Kong. During the event, we engaged in discussions with several professors and emerging researchers to explore the latest advancements and technologies in the field of cancer immunology. Together, we aim to sought new methods to combat cancer.

news_profedwinchan_rthk

香港電台#Hashtag Hong Kong:陳浩然教授專訪

陳浩然教授日前於香港電台節目「#Hashtag Hong Kong」分享他在肌萎縮性脊髓側索硬化症(俗稱「漸凍人症」)及神經退化症十多年病理學研究的心路歷程。

Latest Promotions

bottom of page